ArticleEuropean heart journal open2026
Comparative long-term prognosis of acute myocardial infarction and acute aortic dissection in a population-based registry.
Article in European heart journal open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Acute myocardial infarction (AMI) and acute aortic dissection (AAD) are major cardiovascular emergencies with high mortality; however, their long-term prognoses have rarely been directly compared within the same population. Understanding differences in real-world outcomes between these conditions is important for patient informing and evaluation of cardiovascular care. Methods and results: We analysed 1923 patients enrolled in the Shiga Stroke and Heart Attack Registry, a population-based registry covering an entire Shiga Prefecture in Japan, who developed AMI or AAD between 2014 and 2015. The primary outcome was all-cause death, and the secondary outcome was cardiovascular death during 5-year follow-up. Hazard ratios (HRs) were estimated using multivariable Cox models adjusted for age and sex. Landmark analyses beyond 30 days evaluated outcomes among early survivors. Of the total cohort, 1550 were AMI [ST-elevation myocardial infarction (MI): Conclusion: In this population-based study in Japan, AAD was associated with worse 5-year survival than AMI. Among acute-phase survivors, long-term cardiovascular outcomes were comparable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.